Sosv Investments LLC (F/K/A Sosventures LLC)
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTPS://SOSV.COM/
- HQ
- NJ
Sosv Investments LLC, formerly Sosventures LLC, is a venture firm with a team of general partners including Sean O'Sullivan, Managing General Partner. Its portfolio includes companies such as Cayuga Biotech, Hoofprint Biome, and Formlabs, a 3D printer manufacturer.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Seed |
| Sectors | Climate hardware, Energy, Carbon capture | Not enough dated deals | Hardware, Healthtech, Biotech, Foodtech, Consumer |
| Regions | Not stated | Not enough dated deals | CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 1995 | 2 | Manufacturing, Media |
| 1996 | 1 | Devtools, Gaming, Media |
| 1997 | 1 | Gaming |
| 1998 | 2 | Devtools, Enterprise SaaS, Gaming |
| 1999 | 1 | Hardware |
| 2006 | 1 | Crypto and Web3, Fintech |
| 2007 | 4 | Enterprise SaaS, Insurtech, Devtools |
| 2008 | 3 | Foodtech, Consumer, Ecommerce |
| 2009 | 6 | Marketplaces, Mobility, Climate hardware |
| 2010 | 16 | Hardware, Media, Data analytics |
| 2011 | 25 | Enterprise SaaS, Hardware, Data analytics |
| 2012 | 42 | Hardware, Consumer, Ecommerce |
| 2013 | 86 | Hardware, Enterprise SaaS, Ecommerce |
| 2014 | 111 | Hardware, Ecommerce, Healthtech |
| 2015 | 206 | Hardware, Healthtech, Biotech |
| 2016 | 287 | Hardware, Healthtech, Biotech |
| 2017 | 269 | Hardware, Healthtech, Biotech |
| 2018 | 212 | Hardware, Healthtech, Biotech |
| 2019 | 292 | Biotech, Healthtech, Hardware |
| 2020 | 149 | Biotech, Healthtech, Hardware |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 11 | 3 | 0 | 0 |
| 2011 | 1 | 18 | 2 | 1 | 0 |
| 2012 | 0 | 26 | 3 | 1 | 0 |
| 2013 | 1 | 68 | 4 | 1 | 0 |
| 2014 | 2 | 89 | 2 | 3 | 0 |
| 2015 | 0 | 116 | 3 | 1 | 0 |
| 2016 | 7 | 167 | 4 | 0 | 1 |
| 2017 | 9 | 179 | 7 | 0 | 1 |
| 2018 | 12 | 138 | 9 | 3 | 1 |
| 2019 | 23 | 183 | 19 | 2 | 2 |
| 2020 | 6 | 72 | 10 | 3 | 2 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| SOSV INDIEBIO GENESIS CONSORTIUM II, L.P. | approx. 2023 | Not reported | Open, writing first checks |
| SOSV V LP | 2022 | $130.77M to $179.41M (Form D and SEC adviser filing) | Late investment period |
| SOSV DECARBONIZATION CONSORTIUM, L.P. SOSV is a deep tech venture capital firm that invests at pre-seed, often as a founder's very first check. It backs deep tech founders building companies for human and planetary health. Inferred from the firm's website | 2021 | $20M (Form D) | Late investment period |
| GENESIS CONSORTIUM, L.P. | approx. 2020 | Not reported | Follow-ons only |
| SOSV SELECT FUND LP | approx. 2020 | Not reported | Follow-ons only |
| SOSV IndieBio NY LP | 2020 | $43.55M to $65.03M (Form D and SEC adviser filing) | Follow-ons only |
03 · People across funds
- SEAN O'SULLIVAN, MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
SOSV INDIEBIO GENESIS CONSORTIUM II, L.P. (Named on Form D); SOSV V LP (Named on Form D); SOSV DECARBONIZATION CONSORTIUM, L.P. (Named on Form D)
- Cyril Ebersweiler, General Partner, SOSV & Managing Director, HAX
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Duncan Turner, General Partner & Managing Director, SOSV HAX
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Mohan S. Iyer, General Partner
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Pae Wu, General Partner & Chief Technology Officer
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Po Bronson, General Partner & Managing Director, SOSV SF
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Sean O’Sullivan, Managing General Partner, SOSV
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Stephen Chambers, General Partner & Managing Director, SOSV NY
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Stephen McCann, General Partner & Chief Financial Officer, SOSV
SOSV V LP (Team); SOSV DECARBONIZATION CONSORTIUM, L.P. (Team); SOSV IndieBio NY LP (Team)
- Avra van der Zee, General Partner
On the team page, not linked to a fund
- Deborah Zajac, General Partner
On the team page, not linked to a fund
- Ghaith Alghamdi, Principal
On the team page, not linked to a fund
- Kelly Kirkpatrick, Partner & Director of Investor Relations
On the team page, not linked to a fund
- Sabriya Stukes, Partner, SOSV NY
On the team page, not linked to a fund
- Susan Schofer, Partner & Chief Science Officer
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTPS://SOSV.COM/
- https://sosv.com/
- https://sosv.com/team
- https://sosv.com/portfolio
- https://sosv.com/about
- https://sosv.com/news/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026